Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.6481
Delayed Data
As of Aug 26
 -0.0709 / -9.86%
Today’s Change
0.39
Today|||52-Week Range
4.89
-78.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2006

2007

2008

2009
Operating ActivitiesNet Income / Starting Line83.0K-185.0K-537.9K-1.7M
 
 
 
 
 
Depreciation0.0086.0K2.7K3.6K
 
 
 
 
Total Other Cash Flow-760.0K-1.7M-551.2K378.3K
 
 
 
 
 
Funds From Operations-677.0K-1.8M-1.1M-1.3M
 
 
 
 
 
Funds From/For Other Operating Expenses2.1M14.2M385.2K-75.3K
 
 
 
 
 
Net Cash Flow - Operating Activities-2.8M-16.0M-1.5M-1.2M
 
 
 
 
 
 
InvestingCapital Expenditures-546.0K-468.0K-16.3K-860.00
 
 
 
 
 
Fixed Asset Disposal1.0M41.9M0.000.00
 
 
 
Other Investing - Uses0.00-2.0M-104.0K0.00
 
 
 
Other Investing - Sources3.1M--2.2M4.0M
 
 
 
 
Net Cash Flow Investing3.6M39.4M2.1M4.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--0.000.00--
Long Term Borrowings0.00330.0K0.000.00
 
 
Long Term Debt Reduction-1.4M-943.0K0.000.00
 
 
 
Net Proceeds Stock Sale0.0060.0K0.000.00
 
 
Common Preferred Redeemed0.00-17.5M0.000.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00--------
Other Uses - Financing0.00--38.2K4.1M
 
 
 
Net Cash Flow - Financing-1.4M-18.1M-38.2K-4.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-598.0K5.3M603.3K-1.3M